Stanford Scientists Identify Possible Cause of Rare Heart Inflammation After mRNA Vaccines
Researchers at Stanford Medicine say they have identified a possible biological mechanism behind rare cases of myocarditis linked to mRNA COVID-19 vaccines, offering new insight into how the condition may develop in a small number of patients.
The findings, published in Science Translational Medicine, help explain how the body’s immune response could trigger inflammation of the heart muscle following vaccination. The study focused especially on younger males, who research shows are statistically more likely to experience the rare side effect.
Scientists believe the discovery could contribute to safer vaccine development and help reduce the risk of vaccine-related myocarditis in the future.
Rare but Important to Understand
Medical experts continue to stress that mRNA COVID-19 vaccines remain highly effective and broadly safe for the vast majority of people. Cases of myocarditis after vaccination are considered rare and occur less often than heart inflammation associated with COVID-19 infection itself.
Although some patients may require hospitalization and monitoring, researchers noted that most people diagnosed with the condition recover fully with supportive care.
The study marks another step in ongoing efforts to better understand uncommon vaccine reactions while reinforcing that the overall benefits of vaccination continue to outweigh the risks for most populations.
